SFRP5 and metabolic syndrome: In patients with metabolic syndrome (MetS), circulating Sfrp5 concentrations were lower than in control subjects, they progressively decreased as the MetS components increased, and were negatively correlated with HbA1C and insulin resistance (HOMA-IR) [59].